Changeflow GovPing Consumer Protection EC Clears Charlesbank / Nordic Capital / Tecome...
Routine Rule Added Final

EC Clears Charlesbank / Nordic Capital / Tecomet / Orchid Merger

Favicon for ec.europa.eu EC Competition Cases
Published
Detected
Email

Summary

The European Commission has approved the acquisition of joint control over Tecomet and Orchid by Charlesbank and Nordic Capital under Article 6(1)(b) of the EU Merger Regulation. The decision, issued on 22 April 2026, was a simplified review finding the concentration does not raise doubts as to its compatibility with the common market. The parties operate in the manufacture of medical and dental instruments and supplies sector (NACE Rev. 2.1 code C.32.5). The provisional deadline for the decision was 05.05.2026.

Published by EC on competition-cases.ec.europa.eu . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EC Competition Cases for new consumer protection regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 81 changes logged to date.

What changed

The European Commission issued a clearance decision under Article 6(1)(b) of Council Regulation 139/2004 for the proposed concentration involving Charlesbank, Nordic Capital, Tecomet, and Orchid. This provision applies to concentrations that do not raise competition concerns and do not require further examination. The case was processed under the simplified procedure, reflecting that the transaction does not pose doubts about its compatibility with the common market.

For the parties involved in medical device manufacturing, this clearance means the transaction may proceed without conditions or remedies. The case notification was submitted on 25 March 2026, with the decision issued less than one month later on 22 April 2026. No second-phase investigation was opened.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

M.12319

Merger Simplified Subscribe for updates

CHARLESBANK / NORDIC CAPITAL / TECOMET / ORCHID

Companies: CHARLESBANK | NORDIC CAPITAL | TECOMET | ORCHID Last decision date: 22.04.2026 Case type: Merger Regulation: Council Regulation 139/2004 Notification date: 25.03.2026 Provisional deadline: 05.05.2026 Economic activities: C.32.5 - Manufacture of medical and dental instruments and supplies (NACE Rev. 2.1) Decisions Art. 6(1)(b) of 22.04.2026 Other case related information Prior publication in the OJ: OJEU C/2026/2079 of 07.04.2026 Description of the concentration of 26.03.2026: EN published on 27.03.2026

Named provisions

Art. 6(1)(b)

Mentioned entities

Get daily alerts for EC Competition Cases

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EC.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EC
Published
April 22nd, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
Council Regulation 139/2004
Docket
M.12319

Who this affects

Applies to
Manufacturers Investors
Industry sector
3345 Medical Device Manufacturing
Activity scope
Merger control review Joint venture clearance
Geographic scope
European Union EU

Taxonomy

Primary area
Antitrust & Competition
Operational domain
Regulatory Affairs
Topics
Healthcare Corporate Governance

Get alerts for this source

We'll email you when EC Competition Cases publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!